Published in Obesity and Diabetes Week, September 11th, 2006
Study 1: Metformin may lower coronary risk in hyperinsulinemic women with polycystic ovary syndrome.
"Patients with polycystic ovary syndrome frequently suffer from hyperinsulinemia and adverse lipid profile. This study evaluated effects of metformin on lipid profile," reported scientists at Poznan University.
B. Banaszewska and colleagues explained, "Lipid profiles in hyperinsulinemic (n=43) and normoinsulinemic (n=45) subjects were compared. Hyperinsulinemic subjects were treated with metformin (500 mg po tid) and lipid...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.